ArticleNature2025
Rescuing dendritic cell interstitial motility sustains antitumour immunity.
Abstract read
In one paragraph
Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Reprogramming the tumor microenvironment with oxygen-driven nanomotors for cuproptosis-enhanced immunotherapy.Materials today. Bio · 2026Article
- Article
- Neuroimmune interactions: from molecular mechanisms to therapeutic targets.Molecular biomedicine · 2026Review
- Assessing the therapeutic potential of PDE-5 inhibitors in adults: Insights from a multi-omics study.Physiological reports · 2026Article
- CD5Science advances · 2026Article
- Integrative multi-omics, machine learning, and experimental validation reveal that TPM1 suppresses M2 macrophage polarization and enhances chemosensitivity in acute myeloid leukemia.Cell biology and toxicology · 2026Article
- A plant vesicle-dendritic cell chimera for enhancing cancer immunotherapy.Nature communications · 2026Article
- Attenuating age-related decline in dendritic cell migration improves vaccine efficacy via gut-immune crosstalk.Nature aging · 2026Article
- Pentose phosphate pathway fuels cGAS-STING signalling to boost function of intratumoral conventional dendritic cells.Nature communications · 2026Article
- Preliminary study of cyto-impedance: Molecular profiling of functional impedance in motility-promoting treatment of normal cells.Biochemistry and biophysics reports · 2026Article
- Microwave ablation combined with dendritic cells enhances CD8Cancer immunology, immunotherapy : CII · 2026Article
- Single-cell omics in tumor lymph node metastasis: mechanisms and therapeutic implications.Molecular cancer · 2026Review
- 5-HT reuptake blockade induces pyroptosis in BRAFCell reports. Medicine · 2026Article
- Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer.Human mutation · 2026Review
- The Five-Decade Journey of Small Cell Lung Cancer.Cancer communications (London, England) · 2026Review
- Integrative single-cell and genomic analysis reveals NMB as a driver of metastatic adaptation in esophageal squamous cell carcinoma via metabolic rewiring and immune evasion.Frontiers in cell and developmental biology · 2026Article
- Migrastatics: an overview of the current scenario and future cancer treatments.Frontiers in oncology · 2026Review
- Slc1a2-mediated Glutamate Transport Promotes Dendritic Cell Immunity through Sema3A-regulated Cytoskeletal Remodeling and Migration.International journal of biological sciences · 2026Article
- Exosomes as Pivotal Mediators of Tumor-Immune Communication: Implications for Immunotherapy and Liquid Biopsy.International journal of nanomedicine · 2026Review
- B-type natriuretic peptide attenuates TLR-induced cytokine and chemokine secretion in monocyte-derived Langerhans cells.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Haichao Tang *School of Medicine, Zhejiang University, Hangzhou, China.
Zongfang Wei *Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Bei ZhengWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Yumeng CaiDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Peihan WuWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Lulu WuWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Xiaohe MaWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Yanqin ChenWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Si SuDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jinmin XuWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Yu QiaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Ying ZhangWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Juju MiaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Zijing YuWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.ORCID 0009-0005-1697-3872
Yaodong ZhaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Zhen XiaWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Rongjing ZhouHangzhou Cancer Hospital, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Jian LiuDepartment of Breast Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Jufeng GuoDepartment of Breast Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Zhaoyuan LiuShanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-3117-0833
Qi XieWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.ORCID 0000-0002-2370-2078
Florent GinhouxShanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-2857-7755
Luming ZhaoWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.
Xu LiWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.ORCID 0000-0002-9401-6382
Bing XiaHangzhou Cancer Hospital, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Huanwen WuDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yongdeng ZhangWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China.ORCID 0000-0002-4569-8137
Ting ZhouWestlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China. zhouting@westlake.edu.cn.ORCID 0000-0001-8783-8380
Funding
National Natural Science Foundation of China
Abstract
The dendritic cell (DC)-initiated and sustained cancer immunity cycle is indispensable for effective endogenous and therapeutically mobilized antitumour T cell responses
Indexed as
Cell MovementDendritic CellsNeoplasmsAnimalsCell Line, TumorCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 5FemaleHumansLymph NodesMaleMiceMice, Inbred C57BLMyosin Type IIPhosphodiesterase 5 InhibitorsSildenafil CitrateCyclic GMPCyclic Nucleotide Phosphodiesterases, Type 5Myosin Type IIPhosphodiesterase 5 InhibitorsSildenafil Citrate
Identifiers
PMID
40562926What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.